Point-of-care viral load testing to manage HIV viraemia during the rollout of dolutegravir-based ART in South Africa: a randomised feasibility study (POwER)
<p><strong>Background:</strong> Data is required regarding the feasibility of conducting a randomised trial of <span data-value="point-of-care">point-of-care</span> <span data-value="viral load">viral load</span>...
Main Authors: | Dorward, J, Sookrajh, Y, Lessells, R, Bulo, E, Naidoo, J, Naidoo, K, Bodley, N, Khanyile, M, Van Vuuren, CJ, Moodley, P, Samsunder, N, Lewis, L, Drain, PK, Hayward, G, Butler, CC, Garrett, N |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wolters Kluwer Health
2023
|
Similar Items
-
Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and viraemia in people taking efavirenz and dolutegravir based antiretroviral therapy
by: Dorward, J, et al.
Published: (2023) -
Viremia and HIV drug resistance among people receiving dolutegravir versus efavirenz-based first-line antiretroviral therapy
by: Dorward, J, et al.
Published: (2024) -
Diagnostic accuracy of a point-of-care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz-based antiretroviral therapy
by: Dorward, J, et al.
Published: (2023) -
Protocol for a randomised feasibility study of Point-Of-care HIV viral load testing to Enhance Re-suppression in South Africa: the POwER study
by: Dorward, JJ, et al.
Published: (2021) -
Diagnostic accuracy of a point‐of‐care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz‐based antiretroviral therapy
by: Jienchi Dorward, et al.
Published: (2023-09-01)